Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine long-term outcomes in elderly non-cardiac surgery
NCT04111926Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Oct 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Overall Survival at 3 years. Started Oct 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04111926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111926.